BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35584335)

  • 1. Ocular Manifestations in an Italian Cohort of Patients with Takayasu Arteritis.
    Dammacco R; Cimino L; De Simone L; Alessio G; Dammacco F
    Ocul Immunol Inflamm; 2023 Jul; 31(5):945-954. PubMed ID: 35584335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular manifestations of Takayasu arteritis: a cross-sectional study.
    Peter J; David S; Danda D; Peter JV; Horo S; Joseph G
    Retina; 2011 Jun; 31(6):1170-8. PubMed ID: 21317836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and ocular manifestations of Takayasu arteritis.
    Chun YS; Park SJ; Park IK; Chung H; Lee J
    Retina; 2001; 21(2):132-40. PubMed ID: 11321139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundus manifestation and treatment of Takayasu's arteritis].
    Wang WW; Ye JJ; Chen YX; Dai RP
    Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):124-30. PubMed ID: 22490947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior segment manifestations of Takayasu arteritis: A narrative review.
    Sharma U; Rishi E; Rishi P; Gupta V; Raman R
    Indian J Ophthalmol; 2024 May; 72(5):637-647. PubMed ID: 38648432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ischemic retinopathy in Takayasu disease].
    Loukil I; Mallouch N; Hachicha F; Bhiri R; Hijazi A; Jeddi Blouza A
    Presse Med; 2012 Dec; 41(12 Pt 1):e594-8. PubMed ID: 22647625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OUTCOME OF ENDOVASCULAR PROCEDURES ON OCULAR FINDINGS IN TAKAYASU ARTERITIS.
    Dogra M; Kumar A; Bajgai P; Gupta V; Bansal R; Dogra MR; Vijayvergiya R; Singh R
    Retina; 2019 Jun; 39(6):1142-1148. PubMed ID: 29443797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Management of Ocular Ischemia in Takayasu's Arteritis: A Case-Based Systematic Review.
    Zeng Y; Duan J; Ge G; Zhang M
    Front Immunol; 2021; 12():791278. PubMed ID: 35095866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of anti-VEGF therapy application in Takayasu arteries with retinopathy.
    Gong Q; Qian T; Chen F; Xu X; Wang W
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100706. PubMed ID: 32923739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
    Goel R; Danda D; Kumar S; Joseph G
    Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of fluorescein angiographic study in evaluating early retinal changes in Takayasu disease.
    Baba T; Itakura K; Tanaka R; Kawasaki T; Kiyosawa M; Numano F
    Jpn J Ophthalmol; 1999; 43(6):546-52. PubMed ID: 10672888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Headache and whiteout vision as the presenting symptoms in a case of Takayasu retinopathy.
    Lee JC; Wang MY; Damodar D; Sadun AA; Sadda S
    Retin Cases Brief Rep; 2014; 8(4):273-5. PubMed ID: 25372526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
    Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
    Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular changes in Takayasu's arteritis in India.
    Sagar S; Kar S; Gupta A; Sharma BK
    Jpn J Ophthalmol; 1994; 38(1):97-102. PubMed ID: 7933705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
    Hellmich B; Águeda AF; Monti S; Luqmani R
    Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study.
    Esen F; Ergelen R; Alibaz-Öner F; Çelik G; Direskeneli H; Kazokoğlu H
    Br J Ophthalmol; 2019 Jul; 103(7):928-932. PubMed ID: 30150277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral ocular ischemia-induced blindness as a presenting manifestation of Takayasu arteritis: a case report.
    Pallangyo P; Epafra E; Nicholaus P; Lyimo F; Kazahura P; Janabi M
    J Med Case Rep; 2017 Jun; 11(1):153. PubMed ID: 28599682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Diagnosis and Management of Takayasu Arteritis.
    As C; Danda D
    Int Heart J; 2023; 64(4):519-534. PubMed ID: 37518335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis.
    Peter J; David S; Joseph G; Horo S; Danda D
    Clin Ophthalmol; 2010 Oct; 4():1173-6. PubMed ID: 21060667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.